Quanterix Corporation is developing a novel platform for single
molecule and single cell analysis that will bring a new level of
sensitivity, precision, and robustness to life science research, drug
discovery, and diagnostics applications. The company is backed by
leading life science investors including Arch Ventures, Bain Capital
Ventures, and Flagship Ventures.